NORTHERN CALIFORNIA COMPREHENSIVE SICKLE CELL CENTER
北加州综合镰状细胞中心
基本信息
- 批准号:6388831
- 负责人:
- 金额:$ 228.69万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1978
- 资助国家:美国
- 起止时间:1978-04-01 至 2003-03-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
The objectives of the Northern California Comprehensive Sickle Cell Center
(NCCSCC) are 1) to sponsor and facilitate hemoglobinopathy research at
both fundamental and clinical levels and 2) to provide hemoglobinopathy
detection, counseling, and education to affected populations using the
most modern methods. To pursue these objectives, we have established a
CORE hemoglobin structure and diagnosis laboratory at Childrens' Hospital
Oakland Research Institute (CHORI) and CORE clinical research programs in
the West Bay (UCSF/San Francisco General Hospital) and in the East Bay
(Childrens' Hospital Oakland, Highland Hospital). These programs provide
hemoglobinopathy detection, counseling and education as well as a stable,
well characterized group of over 500 patients with sickle cell disease
(SCD) who participate in NCCSCC research projects. Clinical research
projects aim to a) test the efficacy of core decompression in the
management of aseptic necrosis of bone, b) see whether an acute rise in
serum secretory phospholipase AD heralds the acute chest syndrome and
justifies early therapeutic intervention, and 3) evaluate the efficacy of
potential new therapies (hydroxyurea + phenyl butyrate or clotrimazole,
isobutyramide, oral magnesium, oral chelation and various forms of stem
cell transplantation). More basic cell and molecular biology research
projects will a) exploit our newly developed transgenic mouse model of SCD
(which completely lacks mouse globin chains) to explore the
pathophysiology of SC and evaluate potential new treatments, b) employ a
genome a genome-wide scan to identify genes unlinked to the globin cluster
that alter SCD severity and globin chain switching in inbred strains of
mice, c) use a human b globin YAC specific transgenic mouse model to
define the role of cis-acting regulatory sequences that direct tissue-and
stage-specific expression of the human b globin gene family, and d)
establish a collaborative research venture to explore the effects of
complement, thrombin, and other agonists on the adherence of sickle RBC to
vascular endothelium with the ultimate goal of defining a potential role
for these interactions in sickle vaso-occlusion. These projects will be
carried out at the 2 CORE clinical facilities, CHORI, and laboratories at
UCSF and Lawrence Berkeley National Laboratory. Programs will be
coordinated by Center staff and evaluated by both internal and external
review bodies.
北方加州综合镰状细胞病中心的目标
(NCCSCC)1)赞助和促进血红蛋白病研究
基础和临床水平,以及2)提供血红蛋白病
检测,咨询和教育受影响的人群,
最现代的方法。为达致这些目标,我们设立了一个
儿童医院CORE血红蛋白结构和诊断实验室
奥克兰研究所(CHORI)和CORE临床研究计划,
西湾(UCSF/弗朗西斯科总医院)和东湾
(奥克兰儿童医院,高地医院)。这些方案提供
血红蛋白病检测、咨询和教育以及稳定的,
一组500多名镰状细胞病患者
(SCD)参与NCCSCC研究项目的人。临床研究
项目的目的是a)测试核心减压在
无菌性骨坏死的管理,B)观察是否急性上升,
血清分泌型磷脂酶AD预示急性胸部综合征,
证明早期治疗干预的合理性,3)评估
潜在的新疗法(羟基脲+丁酸苯酯或克霉唑,
异丁酰胺,口服镁,口服螯合剂和各种形式的干
细胞移植)。更多基础细胞和分子生物学研究
项目将a)利用我们新开发的SCD转基因小鼠模型
(完全缺乏小鼠珠蛋白链)来探索
SC的病理生理学并评估潜在的新治疗,B)采用
全基因组扫描,以确定与珠蛋白簇无关的基因
在近交系中改变SCD的严重程度和球蛋白链转换
小鼠,c)使用人B珠蛋白YAC特异性转基因小鼠模型,
定义顺式作用调节序列的作用,
人B珠蛋白基因家族的阶段特异性表达,和d)
建立一个合作研究企业,以探索
补体、凝血酶和其他激动剂对镰状红细胞粘附的影响
血管内皮的最终目标是确定一个潜在的作用,
镰状血管闭塞的相互作用。这些项目将
在2个核心临床机构,CHORI和实验室进行,
UCSF和劳伦斯伯克利国家实验室。节目将
由中心工作人员协调,并由内部和外部评估
审查机构。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
William C. Mentzer其他文献
Human Embryonic ζ-Globin Chains in Fetal and Newborn Blood
- DOI:
10.1182/blood.v74.4.1409.1409 - 发表时间:
1989-09-01 - 期刊:
- 影响因子:
- 作者:
David H.K. Chui;William C. Mentzer;Margaret Patterson;Terri A. Iarocci;Stephen H. Embury;Susan P. Perrine;Reuben S. Mibashan;Douglas R. Higgs - 通讯作者:
Douglas R. Higgs
Thrombocytosis in infants and children
- DOI:
10.1016/s0022-3476(74)80345-8 - 发表时间:
1974-12-01 - 期刊:
- 影响因子:
- 作者:
Joseph E. Addiego;William C. Mentzer;Peter R. Dallman - 通讯作者:
Peter R. Dallman
Developmental change in red blood cell volume: Implication in screening infants and children for iron deficiency and thalassemia trait
- DOI:
10.1016/s0022-3476(76)80390-3 - 发表时间:
1976-10-01 - 期刊:
- 影响因子:
- 作者:
Marion A. Koerper;William C. Mentzer;George Brecher;Peter R. Dallman - 通讯作者:
Peter R. Dallman
G6PD San Francisco: A New Variant of Glucose-6-Phosphate Dehydrogenase Associated With Congenital Nonspherocytic Hemolytic Anemia
- DOI:
10.1182/blood.v55.2.195.195 - 发表时间:
1980-02-01 - 期刊:
- 影响因子:
- 作者:
William C. Mentzer;Rosalind Warner;Joseph Addiego;Byron Smith;Thomas Walter - 通讯作者:
Thomas Walter
Bone marrow transplantation for sickle cell disease. The United States experience.
骨髓移植治疗镰状细胞病。
- DOI:
- 发表时间:
1994 - 期刊:
- 影响因子:0
- 作者:
F. Johnson;William C. Mentzer;K. Kalinyak;K. Sullivan;Miguel R. Abboud - 通讯作者:
Miguel R. Abboud
William C. Mentzer的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('William C. Mentzer', 18)}}的其他基金
NORTHERN CALIFORNIA COMPREHENSIVE SICKLE CELL CENTER
北加州综合镰状细胞中心
- 批准号:
2901028 - 财政年份:1978
- 资助金额:
$ 228.69万 - 项目类别:
NORTHERN CALIFORNIA COMPREHENSIVE SICKLE CELL CENTER
北加州综合镰状细胞中心
- 批准号:
3108483 - 财政年份:1978
- 资助金额:
$ 228.69万 - 项目类别:
相似海外基金
SICKLE CELL ANEMIA AND OTHER HEMOGLOBINOPATHIES
镰状细胞性贫血和其他血红蛋白病
- 批准号:
3097799 - 财政年份:1982
- 资助金额:
$ 228.69万 - 项目类别:
SICKLE CELL ANEMIA AND OTHER HEMOGLOBINOPATHIES
镰状细胞性贫血和其他血红蛋白病
- 批准号:
3097797 - 财政年份:1982
- 资助金额:
$ 228.69万 - 项目类别:
SICKLE CELL ANEMIA AND OTHER HEMOGLOBINOPATHIES
镰状细胞性贫血和其他血红蛋白病
- 批准号:
3097800 - 财政年份:1982
- 资助金额:
$ 228.69万 - 项目类别:
SICKLE CELL ANEMIA AND OTHER HEMOGLOBINOPATHIES
镰状细胞性贫血和其他血红蛋白病
- 批准号:
3097798 - 财政年份:1982
- 资助金额:
$ 228.69万 - 项目类别:
SICKLE CELL ANEMIA AND OTHER HEMOGLOBINOPATHIES
镰状细胞性贫血和其他血红蛋白病
- 批准号:
3097801 - 财政年份:1982
- 资助金额:
$ 228.69万 - 项目类别:
SICKLE CELL ANEMIA AND OTHER HEMOGLOBINOPATHIES
镰状细胞性贫血和其他血红蛋白病
- 批准号:
3097796 - 财政年份:1982
- 资助金额:
$ 228.69万 - 项目类别:
NEONATAL SCREENING AND CONSELING PROGRAM FOR SICKLE CELL ANEMIA
新生儿镰状细胞性贫血筛查和咨询计划
- 批准号:
3900737 - 财政年份:
- 资助金额:
$ 228.69万 - 项目类别: